fda compounding semaglutide crackdown news today 2025 proposes a new GLP-1 Compounded Semaglutide & Tirzepatide 2025:

The escalation pattern starting at 2mg regardless of target dose is consistent across all arms above 1mg

Where it comes from Most research-grade retatrutide is synthesized by peptide manufacturers in China

At the 12 mg dose: 28.3% average weight loss (about 70 lbs) 45.3% of patients lost 30% or more of their body weight 65.3% of patients dropped below a BMI of 30 Patients with baseline BMI 35 who stayed for 104 weeks lost 30.3% on average (85 lbs), with no plateau in sight Discontinuation due to side effects: 11.3% at 12 mg vs

Some research suggests tirzepatide users may experience fewer severe GI side effects than expected given its dual mechanism, but responses are highly individual

Understanding the retatrutide cost landscape helps with planning, and bulk purchasing options can reduce per-vial pricing substantially for longer protocols

Editorial Advisory Board Member, Harvard Health Publishing GLP-1 drugs for diabetes and weight loss have proven to be very effective, but they do have side effects